FDA NEWS

Analysts: Discovery Labs sell-off overdone - Forbes
Analysts said Thursday investors are overreacting to news that Discovery Laboratories Inc. will delay its response to the Food and Drug Administration's request for information about the company's Surfaxin drug by three months. Last month, the FDA
Source: www.forbes.com

FDA accused of failure to act on risky painkiller - Fort Lauderdale Sun-Sentinel
WASHINGTON - A prescription painkiller sold under such names as Darvon and Darvocet is too risky to stay on the market, a consumer advocacy group argued Thursday in suing the Food and Drug Administration. Public Citizen petitioned the FDA two years
Source: www.sun-sentinel.com

Pet food stored in filthy conditions seized at Petco hub in Joliet - Chicago Tribune
Federal marshals Thursday confiscated pet food at Petco's distribution center in Joliet after U.S. Food and Drug Administration inspectors found the food was stored in unsanitary conditions. FDA employees discovered "widespread and active rodent and
Source: www.chicagotribune.com

Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial - Forbes
CALGARY, June 20 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following U.S. Food and Drug Administration (FDA) review, the Company is initiating a U.S. Phase 2 clinical trial using
Source: www.forbes.com